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Abstract
Background
Allergic rhinitis (AR) is the most common allergic disease but little is known about the differ-
ence of local immune responses in children and adults with AR.
Objective
To compare local immune responses between children and adults with AR and nonallergic
rhinitis (NAR), and to investigate whether the association of local and systemic immune
responses is different between the two age groups.
Methods
Fifty-one patients with chronic rhinitis were enrolled and grouped into children (N = 27,
mean age 7.2 years) and adults (N = 24, mean age 29.9 years). Diagnosis of AR was based
on symptoms, skin prick tests and serum specific IgEs. Nasal lavage (NAL) fluids were col-
lected from all subjects and used to measure the levels of total IgE, specific IgEs to house
dust mites (Dp and Df), and cytokines (TNF-α, IL-4, IL-10, IL-17A and IFN-γ). Flow cytome-
try was used to measure inflammatory cell types in NAL fluids.
Results
AR had significantly increased local levels of total IgE and specific IgEs to Dp and Df com-
pared with NAR in both age groups (P < 0.05). Nasal eosinophils % (P = 0.01) was signifi-
cantly increased only in children with AR. Local-systemic correlations of total IgE (r = 0.662,
P = 0.000) and eosinophil % (r = 0.461, P = 0.015) between the peripheral blood and NAL
fluids were found only in children. Moreover, children had correlations between total IgE
and eosinophil % in the peripheral blood (r = 0.629, P = 0.001) and in NAL fluids (r = 0.373,
P = 0.061).
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Conclusion
Elevated local IgE is a common feature of AR in children and adults. Local measures in
NAR showed naïve state of immune response which disagree with the hypothesis of local
allergic rhinitis. Children showed intense local inflammation and close local-systemic inter-
actions compared to adults supporting pediatric AR as a distinct feature.
Introduction
Allergic rhinitis (AR) is the most common allergic disease with a high economic burden [1].
AR has been reported as to affect 36%-40% of children and 10%-30% of adults [2–5]. The prev-
alence of AR has progressively increased in Westernized countries over the past three decades.
AR can be diagnosed by history and clinical symptoms, and through the demonstration of
specific IgE to common inhalant allergens by skin prick tests (SPTs) and in vitro assays [6].
When the results of these tests are negative, rhinitis is classified into nonallergic rhinitis
(NAR), including a heterogeneous group of infectious, occupational and vasomotor rhinitis
[7]. Recently, local allergic rhinitis (LAR) has been emerging as a new endotype of rhinitis,
characterized by positive responses to nasal provocation tests and/or local synthesis of specific
IgE in the absence of systemic atopy [1, 8]. Thus, the current scheme for differential diagnosis
of rhinitis, which is dependent on IgE-mediated systemic immune response, does not seem to
be sufficient. In addition, roles of the local immune response and the association between local
and systemic counterparts need to be elucidated in patients with AR and NAR.
Nasal lavage (NAL) is a non-invasive procedure to collect nasal secretions, which provides
information on local nasal immunity in patients with rhinitis. House dust mite-specific IgE
was observed in the nasal secretions of adults with NAR as well as those with AR [9]. The find-
ing of rye grass pollen-specific IgG, IgA, and IgE in the nasal secretions and sera of patients
with AR suggests that the nasal mucosa may be the source of allergen-specific IgE in peripheral
blood [10]. Although a few studies have measured nasal cytokines in children with AR [11, 12],
little is known about local immunity in children with AR. Moreover, there is no information
available on local immunity changing from children to adults with AR.
AR can develop during early childhood and the prevalence decreases with age [13, 14].
Allergic symptoms and skin test reactivity become milder over time [15]. Thus, nasal inflam-
mation in AR is not simply caused by IgE-mediated eosinophilic inflammation, but rather it is
a dynamic and chronic process involving interactions with environmental factors such as aller-
gens, microbes and air pollutants [16, 17]. Moreover, local immune responses can be continu-
ally balancing over the two axes of pro-inflammatory and regulatory directions.
The aims of this study were to compare local immune responses between children and
adults with AR and NAR, and to investigate whether the association of local immune response
with systemic parameters is different with aging process.
Materials and Methods
Patients
We enrolled 51 consecutive patients (27 children and 24 adults) with AR or NAR between
October 2013 and February 2014. Exclusion criteria included chronic rhinosinusitis (with or
without nasal polyposis), fungal sinusitis, asthma, aspirin intolerance, history of nasal surgery,
and paranasal sinus tumors. Adults (male 83.3%, age range 18–60, mean age 29.9 years) were
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comorbid with septal deviation and children (male 62.9%, age range 3–13, mean age 7.2 years)
were comorbid with adenotonsillar hypertrophy. None of the subjects used antibiotics or nasal
corticosteroids within 4 weeks.
All patients had rhinitis symptoms, including nasal obstruction, rhinorrhea and sneezing,
and underwent assays for serum total IgE and complete blood count (CBC). SPTs were per-
formed to determine their sensitivity to commonly inhaled allergens and the reaction was
regarded as positive if the mean wheal diameter was 3 mm or greater [18]. The diagnosis of AR
and NAR was defined according to the recently published criteria [19]. Nasal endoscopy and
computed tomography were performed for differential diagnosis in adults.
Two Consent forms were prepared for children aged 13 years and children aged 7–12
years to understand objects, benefits, and harms of this study. And we obtained informed con-
sents from both children and their parents. We used questionnaire reporting their nasal symp-
toms (itching, sneezing, rhinorrhea, and obstruction) with four-point scale (0 = no symptom;
1 = mild; 2 = moderate; 3 = severe) [20]. The total nasal symptom score (TNSS) was calculated
as the sum of the scores in each domain. Quality of life (QOL) was measured on a 10-point
visual analog scale (VAS). The study was approved by the Institutional Review Board of Han-
yang University Medical Center (HYI 12–012).
Tissue sampling
Nasal lavage was performed as described previously [21]. Briefly, after induction of general
anesthesia with head-down position, each nostril was flushed with 5 ml of isotonic saline. The
fluid was aspirated with a suction collector under the nasal endoscopy and immediately trans-
ferred to the laboratory bench. Crust and debris were removed with a cell strainer (100 μm,
SPL, Pocheon, Gyeonggi-do, South Korea) and the fluids were immediately centrifuged at
6,000 rpm for 5 min. The supernatants were decanted and stored at -80°C. The cell pellets were
resuspended in 1 ml of Dulbecco’s phosphate buffered saline (PBS) containing 2% fetal bovine
serum (FBS) for flow cytometry.
Flow cytometry
Non-specific antibody binding was blocked by incubating cells with TruStain FcX (eBioscience,
San Diego, CA, USA) on ice for 15 minutes. The cells were subsequently incubated with mono-
clonal antibodies (Table 1) on ice for 30 minutes. The monoclonal antibodies included anti-
human CD45 (HI30, BioLegend, San Diego, CA, USA) for whole leukocytes, anti-human CD3
(HIT3a, BD Pharmingen, San Jose, CA, USA) for T cells, anti-human CD14 (HCD14, M5E2,
BioLegend, San Diego, CA, USA) for macrophages, anti-human CD19 (HIB19, BioLegend, San
Table 1. Antibody panel for leukocyte surface proteins associated with nasal lavage cells.
Target molecule Host Clone Company
HLA-DR mouse L243 BioLegend
HLA-DR mouse LN3 eBioscience
CD3 mouse HIT3a BD Pharmingen
CD11c mouse 3.9 BioLegend
CD14 mouse HCD14 BioLegend
CD14 mouse M5E2 BioLegend
CD16 mouse 3G8 BioLegend
CD19 mouse HIB19 BioLegend
CD45 mouse HI30 BioLegend
doi:10.1371/journal.pone.0156979.t001
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Diego, CA, USA) for B cells, anti-human CD11c (3.9, BioLegend, San Diego, CA, USA) for
dendritic cells, anti-human CD16 (3G8, BioLegend, San Diego, CA, USA) for granulocytes
including neutrophils and eosinophils, and anti-human HLA-DR (L243, BioLegend, LN3,
eBioscience, San Diego, CA, USA) for dendritic cells and B cells. Flow cytometry was per-
formed using a FACS Canto II (BD Biosciences, San Jose, CA, USA) and data were analyzed
using Flow Jo ver. 9.3.2 (Treestar, Inc., San Carlos, CA, USA) (Fig 1).
CAPmeasurement of immunoglobulins, superantigens, and ECP in the
NAL fluids
To evaluate local antibody production, we measured total IgE and specific IgEs for house dust
mites (Dermatophagoides pteronyssinus; Dp and Dermatophagoides farinae; Df) and superanti-
gens (staphylococcus enterotoxins A; SEA and staphylococcus enterotoxins B; SEB) in NAL
fluids. To monitor the allergic response, we also measured eosinophil cationic peptide (ECP) in
NAL fluids. All analyses were performed using the ImmunoCAP system (Phadia, Uppsala,
Sweden). IgE concentrations were expressed as kU/L and ECP as μg/L [22, 23].
Enzyme-linked immunosorbent assays (ELISA)
The concentrations of interleukin-4 (IL-4), IL-10, IL-17A, interferon-γ (IFN-γ) (R&D Systems,
Minneapolis, MN, USA), and tumor necrosis factor-α (TNF-α, BD Biosciences, San Jose, CA,
Fig 1. Gating strategy.Cell populations were incubated with antibodies against CD45, CD3, CD14, CD19, HLA-DR, CD11c, and CD16.
The expression of surface markers on CD45+ leukocytes was analyzed by flow cytometry: CD3- CD14+ macrophages, CD3+ CD14- T cells,
CD3- CD14- CD19+ HLA-DR+ B cells, CD3- CD19- CD11c+ HLA-DR+ CD14- dendritic cells, CD3- CD14- CD19- CD11c- CD16high
neutrophils, and CD3- CD14- CD19- CD11c- CD16intermediate eosinophils.
doi:10.1371/journal.pone.0156979.g001
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USA) were measured in NAL fluids using commercially available ELISA kits, according to the
manufacturers' protocols.
Statistics
Because of the relatively small sample size and the non-normal distribution, continuous vari-
ables are presented as medians with/without an interquartile range instead of as means with/
without standard deviations. Statistical significance (P< .05) was analyzed using the Mann-
Whitney U test. The relationships between systemic and local allergic parameters were exam-
ined using Spearman correlation analysis. Receiver-operating characteristic (ROC) curve anal-
ysis was used to determine the AR cutoff in adults and children with optimal sensitivity and
specificity. All statistical analyses were performed using Graph-Pad Prism ver. 5.0 (Graph-Pad
Software Inc., San Diego, CA, USA) and IBM SPSS ver. 21.0 (IBM Co., Armonk, NY, USA).
Results
Clinical characteristics of subjects with AR and NAR
The clinical characteristics of the study subjects are summarized in Table 2. The AR group was
younger in adults (P = 0.011) but older in children (P = 0.043) than their respective NAR group.
Sex (%), TNSS, and QOL were not significantly different between AR and NAR in either age
group. House dust mites (Dp and Df) were the most common allergen in children (100%) and
adults (73.3%) with AR. There was no correlation between TNSS and nasal IgE levels regardless
of rhinitis types and age groups (not shown). The volumes of NAL fluids recovered after wash-
ing the nasal cavity with 10 mL of saline were not significantly different among the groups.
The levels of serum total IgE (P = 0.016) and blood eosinophil % (P = 0.001) were signifi-
cantly increased in AR compared to NAR in children (Table 3). However in adults, they were
not different between AR and NAR (Table 4).
Local immune response in the nasal airway of children with AR
In children, flow cytometry of the NAL fluids showed a significant increase in eosinophils
(P = 0.01) and a decrease in macrophages (P = 0.005) in AR compared with NAR (Table 3).
Table 2. Epidemiologic and clinical characteristics of the study subjects.
Characteristics Children Adults
NAR AR NAR AR
N 12 15 9 15
Sex (M:F) 10:2 7:8 7:2 13:2
Age (yr) 5.0 (4.0–7.8) 8.0 (6.0–11.0) 36.0 (26.0–49.5) 23 (19–33.0)
TNSS 5.5 (4.0–7.8) 6.0 (4.0–8.0) 7.0 (3.0–7.0) 7.0 (5.0–9.0)
QOL 5.0 (4.3–5.0) 5.0 (4.0–6.0) 4.0 (2.0–6.0) 4.0 (2.5–5.0)
Skin prick test
Dp 0% 86.7% 0% 60%
Df 0% 93.3% 0% 73.3%
pollens 0% 6.7% 0% 33.3%
cat or dog 0% 20% 0% 26.7%
Continuous variables are presented as median with interquartile range. NAR: nonallergic rhinitis, AR: allergic rhinitis, TNSS: total nasal symptom score,
QOL: quality of life, Dp: Dermatophagoides pteronyssinus, Df: Dermatophagoides farinae.
doi:10.1371/journal.pone.0156979.t002
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CAP analysis of the NAL fluids showed significantly increased levels of total IgE (P = 0.01),
Dp-specific IgE (P = 0.001) and Df-specific IgE (P = 0.001) in AR compared with NAR. Macro-
phages (%) had negative correlations with total IgE (r = -0.558, P = 0.003), Dp-IgE (r = -0.446,
P = 0.023), and Df-IgE (r = -0.445, P = 0.023) in NAL fluids. However, there was no difference
in the levels of specific IgE to superantigens (SEA and SEB), ECP, and other T cell cytokines
(including IL-10) in NAL fluids between the subgroups in children.
Local immune response in the nasal airway of adults with AR
In adults, CAP analysis of the NAL fluids showed significantly increased levels of total IgE
(P = 0.019), Dp-specific IgE (P = 0.006) and Df-specific IgE (P = 0.003) in AR compared with
NAR (Table 4). However, no inflammatory cells including macrophages, dendritic cells, and
eosinophils were different in the NAL fluids between AR and NAR. In addition, there was no
difference in the levels of specific IgE to superantigens (SEA and SEB), ECP, and other T cell
cytokines (including IL-10) in NAL fluids between the subgroups in adults.
Comparison of local and systemic immune parameters between children
and adults
To compare the local and systemic immune responses between children and adults, we per-
formed subgroup analyses of subjects with AR sensitized to only house dust mites. Blood
Table 3. Systemic (blood) and local (nasal lavage fluid) immune parameters in children with NAR and AR.
Parameters Children NAR (n = 12) Children AR (n = 15) P value
Systemic immunity Total IgE (IU/ml) 41.9 (19.4–193.3) 269.7 (96.9–559.5) 0.016*
Eosinophils (%) 1.8 (1.1–2.3) 5.6 (3.5–8.0) 0.001**
Local cellular immunity WBC count (/mm3) 92,558 (36,320–156,962) 47,471 (26,493–144,849) 0.495
Macrophages (%) 1.6 (0.8–3.1) 0.6 (0.3–0.9) 0.005**
Dendritic cells (%) 2.5 (0.4–3.7) 1.6 (0.7–2.6) 0.884
T cells (%) 3.4 (2.6–7.4) 3.3 (2.1–7.0) 0.733
B cells (%) 17.0 (7.1–35.3) 13.5 (9.5–20.3) 0.696
Neutrophils (%) 37.8 (23.8–51.5) 38.4 (25.0–57.0) 0.845
Eosinophils (%) 9.5 (4.8–13.0) 15.0 (11.4–23.5) 0.010*
Local humoral immunity Total IgE (kU/L) 4.00 (3.25–4.20) 8.14 (4.88–16.78) 0.001**
Dp-IgE (kU/L) 0.10 (0.07–0.13) 0.86 (0.29–4.58) 0.001**
Df-IgE (kU/L) 0.12 (0.08–0.12) 2.41 (0.79–4.44) 0.001**
SEA-IgE (kU/L) 0.08 (0.07–0.09) 0.10 (0.07–0.10) 0.209
SEB-IgE (kU/L) 0.07 (0.05–0.08) 0.08 (0.07–0.09) 0.159
ECP (μg/L) 31.0 (15.1–82.6) 59.65 (27.90–151.50) 0.149
TNF-α (pg/ml) 2.07 (0.00–22.94) 0.24 (0.00–4.97) 0.465
IL-4 (pg/ml) 0.08 (0.00–2.53) 0.72 (0.00–3.08) 0.550
IL-10 (pg/ml) 14.41 (3.90–100.95) 3.51 (0.00–17.04) 0.055
IL-17A (pg/ml) 0.00 (0.00–0.75) 0.00 (0.00–2.43) 0.947
IFN-γ (pg/ml) 5.89 (0.00–50.71) 19.29 (2.77–28.57) 0.422
Continuous variables are presented as median with interquartile range. NAR: nonallergic rhinitis, AR: allergic rhinitis, Dp: Dermatophagoides
pteronyssinus, Df: Dermatophagoides farina, SEA: Staphylococcus enterotoxin A, SEB: Staphylococcus enterotoxin B, ECP: eosinophil cationic protein,
TNF-α: tumor necrosis factor-alpha, IL: interleukin, IFN-γ: interferon-gamma.
*P < 0.05
**P < 0.01
doi:10.1371/journal.pone.0156979.t003
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eosinophil % (P = 0.02) were significantly higher in children than in adults, but the levels of
serum total IgE were not different between the two groups (P = 0.827). In NAL fluids, eosino-
phil % (P = 0.036) were significantly increased in children compared to adults (Fig 2A). How-
ever, the levels of total IgE and specific IgEs to house dust mites were not different between the
two groups (Fig 2B). Nasal concentrations of IL-10 (P = 0.021) and IFN-γ (P = 0.038) were sig-
nificantly increased in children compared to adults (Fig 2C). However, the local levels of spe-
cific IgE to super-antigens, ECP, and other T-cell cytokines were not significantly different
between the two groups (Fig 2B and 2C).
Regardless of atopic status, flow cytometry of the NAL fluids showed a significant increase
in B cells and a decrease in T cells in children compared to adults (Fig 2A and 2D). In the NAR
groups, the local measurements of other parameters did not show any differences between chil-
dren and adults (Fig 2D–2F).
Association of local and systemic immune responses in children and
adults
We found significant local-systemic correlations of total IgE (r = 0.662, P = 0.001, Fig 3A) and
eosinophil % (r = 0.461, P = 0.015, Fig 3B) between the NAL fluids and peripheral blood in
children. However, these correlations were not found in adults (Fig 3A and 3B). In children,
the correlation between total IgE and eosinophil % was significant in the peripheral blood
Table 4. Systemic (blood) and local (nasal lavage fluid) immune parameters in adults with NAR and AR.
Parameters Adults NAR (n = 9) Adults AR (n = 15) P value
Systemic immunity Total IgE (IU/ml) 53.0 (34.8–153.7) 286.20 (50.9–845.6) 0.121
Eosinophils (%) 2.0 (1.6–2.9) 3.2 (1.1–4.1) 0.455
Local cellular immunity WBC count (/mm3) 10,733 (3,960–98,313) 14,947 (6,155–27,781) 0.655
Macrophages (%) 1.0 (0.4–8.2) 0.50 (0.2–1.5) 0.161
Dendritic cells (%) 1.5 (0.7–2.8) 0.8 (0.4–1.1) 0.060
T cells (%) 15.4 (4.6–34.9) 22.3 (5.4–37.6) 0.788
B cells (%) 5.2 (4.2–14.1) 5.2 (1.2–9.6) 0.633
Neutrophils (%) 60.0 (24.1–71.0) 40.6 (27.4–70.3) 0.698
Eosinophils (%) 4.7 (2.2–12.8) 3.9 (1.3–17.6) 0.698
Local humoral immunity Total IgE (kU/L) 4.36 (3.09–4.71) 6.95 (5.30–11.60) 0.019*
Dp-IgE (kU/L) 0.14 (0.07–0.14) 0.24 (0.18–1.09) 0.006**
Df-IgE (kU/L) 0.12 (0.08–0.13) 0.30 (0.17–1.58) 0.003**
SEA-IgE (kU/L) 0.07 (0.06–0.09) 0.09 (0.07–0.10) 0.184
SEB-IgE (kU/L) 0.07 (0.06–0.09) 0.08 (0.07–0.10) 0.117
ECP (μg/L) 17.1 (5.2–42.4) 34.0 (15.6–73.4) 0.101
TNF-α (pg/ml) 5.92 (0.00–19.09) 1.10 (0.00–4.05) 0.188
IL-4 (pg/ml) 0.72 (0.00–4.06) 1.28 (0.00–6.28) 0.692
IL-10 (pg/ml) 0.00 (0.00–33.13) 0.00 (0.00–0.00) 0.071
IL-17A (pg/ml) 0.00 (0.00–0.00) 0.00 (0.00–0.00) 0.795
IFN-γ (pg/ml) 15.71 (1.25–63.57) 4.64 (0–11.79) 0.176
Continuous variables are presented as median with interquartile range. NAR: nonallergic rhinitis, AR: allergic rhinitis, Dp: Dermatophagoides
pteronyssinus, Df: Dermatophagoides farinae, SEA: Staphylococcus enterotoxin A, SEB: Staphylococcus enterotoxin B, ECP: eosinophil cationic protein,
TNF-α: tumor necrosis factor-alpha, IL: interleukin, IFN-γ: interferon-gamma.
*P < 0.05
**P < 0.01
doi:10.1371/journal.pone.0156979.t004
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(r = 0.629, P = 0.001, Fig 3C) but not in the NAL fluids (r = 0.373, P = 0.061, Fig 3D). And
these findings were also not found in adults (Fig 3C and 3D).
ROC curves of local immune parameters for AR in children and adults
ROC curves of the local immune parameters were constructed to evaluate their ability to diag-
nose AR in children and adults based on their cut-off values, sensitivity, and specificity
(Table 5). The areas under the curves (AUC) for the diagnosis of AR were significant for total
IgE (P = 0.001 and P = 0.004, respectively), and specific IgEs to Dp (P = 0.001 and P = 0.007,
respectively) and Df (P = 0.001 and P = 0.005, respectively) measured in NAL fluids from chil-
dren and adults. However, nasal eosinophils % (cut-off = 13.9%, AUC = 0.821, P = 0.007) was
significant for the diagnosis of AR only in children.
Discussion
This study analyzed cellular and humoral immune responses in NAL fluids from children and
adults with AR and NAR, and their local-systemic associations. Additionally, we investigated
whether children with AR have a different immunologic phenotype from adults with AR. Our
findings can be summarized as follows: (1) Increased production of total and allergen-specific
IgEs was found in the nasal airways of AR compared with NAR in both age groups. (2) In AR,
children had higher levels of eosinophilic inflammation in both peripheral blood and the nasal
airway than adults. (3) Local-systemic correlations of total IgE and eosinophil % were signifi-
cant only in children.
Fig 2. Local immune parameters in children and adults with allergic rhinitis (AR, A-C) and nonallergic rhinitis (NAR, D-F). (A, D), flow
cytometry; (B, E), CAP immunoassay; (C, F), ELISA. *P < 0.05, **P < 0.01.
doi:10.1371/journal.pone.0156979.g002
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AR is a hypersensitivity disease mediated by specific IgE when exposed to inhalant allergens
[6]. IgE is capable to crosslink the high and low affinity receptor (FcεRI) of effector cells (mast
cells and basophils), and starts allergic cascades resulting rhinitis symptoms such as sneezing,
rhinorrhea and nasal obstruction [6, 24]. Although systemic and skin IgE are widely used as in
vivo and in vitro tests, it has been not fully investigated about age-related roles of local IgE and
its systemic interactions.
Increased levels of total IgE and specific IgEs to house dust mites were found in the NAL flu-
ids from children and adults with AR compared to levels measured in their respective NAR
groups. Our findings support the fact that local IgE is a key molecule that drives nasal eosino-
philic inflammation in patients with AR [25, 26]. However, only children with AR showed
increased local eosinophilia, and the significant correlation between total IgE and eosinophils
Fig 3. Correlation analysis of local-systemic interactions in children and adults. (A) Scatter plots and regression lines show interactions of (A)
total IgE between NAL fluids and serum and (B) eosinophilia (%) between NAL fluid and peripheral blood. IgE-mediated eosinophilic inflammation is
shown in the peripheral blood (C) and NAL fluids (D).
doi:10.1371/journal.pone.0156979.g003
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in NAL fluids. Thus, when compared to adults, children with AR seem to have severe atopic
intensity and strong IgE-mediated eosinophilic inflammation.
Local and systemic levels of total IgE and eosinophils showed significant associations in
children but not in adults. Local eosinophilic inflammation may precede systemic eosinophilic
inflammation, as local IgE is the source of serum IgE. Consistent with previous findings [27,
28], the hypothesis of “local-systemic interactions” was also observed in our study. However,
we found discrepancies of local-systemic interactions between children and adults. Previous
studies have reported that children had higher levels of serum total IgE and eosinophils (%)
compared to adults which is consistent to our results [29–31]. Innate and adaptive immune
response can be altered or impaired with increased age, and therefore, our results provided an
evidence supporting the phenomenon of “immunosenescence” in allergic rhinitis which can
explain the loss of local-systemic interactions in adults [31].
Specific IgEs for inhalant allergens (e.g. house dust mite) can be locally produced and spill
over into systemic circulation [28]. Flow cytometry showed plenty of B lymphocytes in NAL
fluids, which may be the source of local IgEs. Because we measured not the membrane-bound
IgE but the secreted form of local IgE, we could not demonstrate their direct roles in the patho-
genesis of AR which needs further investigation.
LAR is characterized by the presence of nasal Th2 inflammation with local production of
specific IgEs and/or a positive response to a nasal allergen provocation test without evidence of
systemic atopy [8]. Previous studies, mostly performed in Western populations, have reported
the prevalence of LAR to be 25.7% in chronic rhinitis [32] and 47%-62.5% in NAR [33–35]. In
this study, we found that local IgEs (total and allergen-specific) were elevated only in AR of
children and adults. In other word, all patients with NAR had low level of local IgE and there
was no case correspondent to LAR. Therefore, we confirmed roles of local IgEs in AR but could
not support the concept of local allergic rhinitis in NAR. This discrepant result is very impor-
tant issue which needs to be re-evaluated by other researchers in Western and Asian countries.
Recent studies have shown that innate immune cells, like macrophages and dendritic cells,
can induce Th2 responses. Macrophages can affect the production of IL-4 or immunoglobulin
and the class switching of lymphocytes in the initiation of mouse AR [30]. In our study, flow
cytometry showed that decreased nasal macrophages in children with AR compared to NAR.
Moreover, macrophages had negative associations with nasal immunoglobulins (total and
Table 5. Cut-off value and areas under the receiver operating characteristics for local immunemarkers in children and adults with AR.
Immune markers Cut-off Sensitivity Speciﬁcity AUC P value
Children AR
Total IgE (kU/L) 4.65 0.846 0.917 0.891 0.001**
Dp-IgE (kU/L) 0.18 0.846 1.000 0.939 0.001**
Df-IgE (kU/L) 0.28 0.846 1.000 0.949 0.001**
Eosinophils (%) 13.86 0.769 0.833 0.821 0.007**
Adults AR
Total IgE (kU/L) 4.69 0.867 0.875 0.875 0.004**
Dp-IgE (kU/L) 0.16 0.800 1.000 0.846 0.007**
Df-IgE (kU/L) 0.14 0.867 0.875 0.867 0.005**
Eosinophils (%) 3.53 0.533 0.500 0.467 0.796
AR: allergic rhinitis, Dp: Dermatophagoides pteronyssinus, Df: Dermatophagoides farinae.
*P < 0.05
**P < 0.01
doi:10.1371/journal.pone.0156979.t005
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specific). Therefore, macrophages may be actively involved in the regulation of allergic
responses in children [36].
Enhanced Th2 cytokine responses and lower levels of IFN-γ from Th1 cells have been
reported in NAL fluid from patients with AR [37–41]. However, our study showed that the lev-
els of nasal Th-related cytokines (Th1, Th2, and Th17) did not differ between patients with AR
and NAR regardless of age group. Local level of IL-10 measured in AR showed declining ten-
dencies compared to NAR in both children and adults. Moreover, children with AR had
increased local levels of IL-10 and IFN-γ compared to adults with AR. Therefore, we concluded
that active pro-Th2 and regulatory responses may occur simultaneously in the nasal airway in
children with AR. In adults, these two axes of immune response wane with aging process.
In conclusion, elevated local IgE is a common feature of AR in children and adults. Local
measures in NAR showed naïve state in immune perspectives having very low levels of all cyto-
kines and immunoglobulins which disagree with the hypothesis of “local allergic rhinitis”. In
addition, children showed intense local inflammation and close local-systemic interaction
compared to adults which support the phenomenon of “immunosenescence” and also suggest
pediatric AR as a distinct feature.
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